Literature DB >> 21056447

Punctate inner choroidopathy.

Radgonde Amer1, Noemi Lois.   

Abstract

Punctate inner choroidopathy (PIC) is a relatively uncommon inflammatory multifocal chorioretinopathy that affects predominantly young myopic women. It is characterized by the presence of multiple, small, well-defined, yellow-white fundus lesions frequently limited to the posterior pole in the absence of flare and inflammatory cells in the anterior chamber or vitreous cavity. Most patients with PIC do not require treatment, as the disease does not often threaten vision; however, when subfoveal choroidal neovascular membrane (CNV) ensues, patients usually lose sight rapidly, requiring immediate care. Treatment modalities that have been used to manage patients with PIC and subfoveal CNV include systemic and local steroids, other immunosuppressant agents, laser photocoagulation, photodynamic therapy, submacular surgery and, most recently, anti-vascular endothelial growth factor therapy. To date, however, there is no clear consensus on the effective therapy. Further research into this area, as well as on the cause and possible predisposing factors for PIC, is warranted.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21056447     DOI: 10.1016/j.survophthal.2010.03.009

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  15 in total

1.  Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to punctate inner choroidopathy.

Authors:  T Barth; F Zeman; H Helbig; M-A Gamulescu
Journal:  Int Ophthalmol       Date:  2017-04-19       Impact factor: 2.031

2.  A 39-year-old woman with unilateral metamorphosias.

Authors:  Lígia Ribeiro; Sidnei Barge; Luís Silva; Arnaldo Brandão; Dália Meira
Journal:  Digit J Ophthalmol       Date:  2011-11-20

3.  Idiopathic multifocal choroiditis/punctate inner choroidopathy with acute photoreceptor loss or dysfunction out of proportion to clinically visible lesions.

Authors:  Marion R Munk; Jesse J Jung; Kristin Biggee; William R Tucker; H Nida Sen; Ursula Schmidt-Erfurth; Amani A Fawzi; Lee M Jampol
Journal:  Retina       Date:  2015-02       Impact factor: 4.256

4.  Outcomes of adalimumab therapy in refractory punctate inner choroidopathy and multifocal choroiditis.

Authors:  Or Shmueli; Radgonde Amer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-01-04       Impact factor: 3.117

5.  Presumed idiopathic central serous chorioretinopathy in a 12-year-old girl.

Authors:  Juan P Velazquez-Martin; Emiliano Fulda; Daniela Domville; Federico Graue-Wiechers; Hatem Krema
Journal:  Case Rep Ophthalmol       Date:  2012-01-20

6.  Classification Criteria for Punctate Inner Choroiditis.

Authors: 
Journal:  Am J Ophthalmol       Date:  2021-04-15       Impact factor: 5.488

Review 7.  Punctate inner choroidopathy: a systematic review.

Authors:  Joana Campos; António Campos; Sílvia Mendes; Arminda Neves; Diana Beselga; Jp Castro Sousa
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2014

8.  Punctate Inner Choroidopathy.

Authors:  Mariana Sá-Cardoso; Arnaldo Dias-Santos; Natália Nogueira; Heloísa Nascimento; Rubens Belfort-Mattos
Journal:  Case Rep Ophthalmol Med       Date:  2015-04-28

9.  Adjunctive use of systematic retinal thickness map analysis to monitor disease activity in punctate inner choroidopathy.

Authors:  Savitha Madhusudhan; Pearse A Keane; Alastair K Denniston
Journal:  J Ophthalmic Inflamm Infect       Date:  2016-03-10

Review 10.  Idiopathic Multifocal Choroiditis.

Authors:  Ali Tavallali; Lawrence A Yannuzzi
Journal:  J Ophthalmic Vis Res       Date:  2016 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.